Literature DB >> 17181127

Two non-invasive diagnostic tools for invasive aspergilosis: (1-3)-beta-D-glucan and the galactomannan assay.

Amy Kelaher1.   

Abstract

Invasive aspergillosis (IA) is a serious cause of morbidity and mortality among immunocompromised patients. Prompt and non-invasive methods for diagnosing IA are needed to improve the management of this life-threatening infection in patients with hematological disorders. In summary, this retrospective review of studies performed on the two assays finds that both assays have high sensitivity and specificity but are more useful when used together as a diagnostic strategy for patients with invasive aspergillosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17181127

Source DB:  PubMed          Journal:  Clin Lab Sci        ISSN: 0894-959X


  3 in total

1.  The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.

Authors:  G Metan; C Ağkuş; H Buldu; A N Koç
Journal:  Infection       Date:  2010-03-17       Impact factor: 3.553

2.  Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.

Authors:  E Furfaro; M Mikulska; V Del Bono; F Guolo; P Minetto; M Gobbi; A Ghiso; A Bacigalupo; C Viscoli
Journal:  Clin Vaccine Immunol       Date:  2014-07-02

3.  Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Florence Persat; Stéphane Ranque; Francis Derouin; Annie Michel-Nguyen; Stéphane Picot; Annie Sulahian
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.